Author | Lightnews

Zyme Communications

@zymecommunications.bsky.social

28 followers 71 following 110 posts

Specialist communications for life sciences

Posts Media Videos Starter Packs

Pinned

Zyme Communications @zymecommunications.bsky.social · Feb 18

A lovely way to start the year – Zyme is named #1 Marketing Agency by @businessweekly.bsky.social, with reference to the quality of our work, our global expansion, and recruitment. Congratulations to all the agencies listed in the top 10, and thank you Tony Quested and of course our brilliant team!

Zyme Communications @zymecommunications.bsky.social · 8h

Today Optibrium introduced the latest release of its comprehensive molecular design platform, StarDrop 8, integrating collaboration at every stage of the discovery process enabling medicinal chemists to progress more quickly from hit to candidate.

Read more here: bit.ly/4nGfpn9

Zyme Communications @zymecommunications.bsky.social · 1d

Today Nuclera announced expanded access to its eProtein Discovery System for APAC customers through a distributor agreement with Solve Scientific in Australia and New Zealand, providing localised support and expertise to scientists in these regions.

bit.ly/3LsJYz3

Zyme Communications @zymecommunications.bsky.social · 5d

@proimmune.bsky.social has introduced ProVE SL Self-Loading Class I Monomers, designed to offer unprecedented flexibility, speed and MHC allele-coverage in T cell research, with over 50 alleles available.

Read more: www.proimmune.com/news

Zyme Communications @zymecommunications.bsky.social · 5d

VALANX Biotech has appointed Klaus Orlinger, PhD. as CSO.

Klaus is an experienced R&D leader with a distinguished track record in pharmaceutical product development joining VALANX from HOOKIPA Pharma, where he served as CSO, VP Research, and Head of Virology.

Read more here: rb.gy/qva8kz

Zyme Communications @zymecommunications.bsky.social · 8d

Today Qureight announced that its Vascul8™ model for pulmonary vascular disorders has been validated in a peer reviewed study, offering the potential to improve treatment options and patient outcomes following surgery.

Read the full press release here: bit.ly/48OeEo5

Zyme Communications @zymecommunications.bsky.social · 12d

OMED Health, part of @owlstonemedical.bsky.social, has partnered with Aviva to deliver a pilot study, providing 75 Aviva employees with OMED Health Plans.

The collaboration will evaluate the impact of the OMED solution on the digestive health of participants: www.owlstonemedical.com/about/news/2...

Zyme Communications @zymecommunications.bsky.social · 13d

Biodesix has expanded its partnership agreement with @biorad24.bsky.social to develop in vitro diagnostic assays for highly sensitive detection of genomic markers focused on oncology applications, utilizing Bio-Rad’s ddPCR™ technology & QX600 platform.

More here: rb.gy/5wbz3q

Zyme Communications @zymecommunications.bsky.social · 13d

@proimmune.bsky.social has expanded into new global headquarters at Oasis Park, Oxford, supporting the continued development of ProImmune’s REVEAL Immunogenicity System and Ankyron target binding technologies.

Read more: proimmune.com/news

Zyme Communications @zymecommunications.bsky.social · 13d

giles AI has introduced giles, its specialised research agent designed to support healthcare, clinical, and medical research by optimising research intelligence for scientific text comprehension, enabling extraction and summarisation of academic papers: giles.app/press-releas...

Zyme Communications @zymecommunications.bsky.social · 14d

Bio-Rad Laboratories today announced that MicroVal, the international certification organization, has approved the iQ-Check Enterobacteriaceae Kit for real time detection of Enterobacteriaceae in infant formula, infant cereal, and related ingredients: www.bio-rad.com/en-uk/life-s...

Zyme Communications @zymecommunications.bsky.social · 14d

Today Enamine announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of ASAP-0017445, a promising broad-spectrum coronavirus antiviral pre-clinical candidate.

Read more: enamine.net/news-press-r...

Zyme Communications @zymecommunications.bsky.social · 15d

.@MosaicTXLtd has appointed Thomas Fuchs as CEO.

With over 25 years of experience across drug development and commercialisation, Thomas will lead the Company to advance its pipeline of proprietary drug combination programmes into the clinic: mosaic-tx.com/wp-content/u...

Zyme Communications @zymecommunications.bsky.social · 15d

Cyclana Bio today announced the close of a £5M pre-seed funding round that will enable the Company to develop functional disease models and its platform, for the identification of druggable targets in endometriosis.

More here: www.cyclanabio.com/general-8

Zyme Communications @zymecommunications.bsky.social · 21d

@sptlabtech.bsky.social and @10xgenomics.bsky.social have partnered to provide automated workflows for single cell research, scaling experiments on 10x’s Chromium Single Cell platform using plug-and-play protocols on SPT Labtech’s firefly platform: www.sptlabtech.com/news/spt-lab...

1 2

Zyme Communications @zymecommunications.bsky.social · 21d

This morning, CN Bio announced the launch of its all-in-one Organ-on-a-chip system, PhysioMimix Core.

The system combines the capabilities of CN Bio’s existing suite of instruments, enabling single-, multi-organ and higher-throughput configurations within one scalable platform.

bit.ly/3W6HxEv

Zyme Communications @zymecommunications.bsky.social · 27d

@sptlabtech.bsky.social and Agilent Technologies have introduced automated targeted enrichment protocols for genomic workflows. The protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kits to increase reproducibility and reduce costs: tinyurl.com/5fmtwuf5

Zyme Communications @zymecommunications.bsky.social · 27d

FairJourney Biologics today announced the appointment of Dr. Werner Lanthaler as CEO, who previously served as Evotec SE CEO for 15 years.

Founder António Parada will focus on driving the Company's innovation strategy on the Supervisory Board.

Read more here: rb.gy/c31dis

Zyme Communications @zymecommunications.bsky.social · 29d

Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the POSEIDON program, which aims to develop synthetic-sensor based Multi Cancer-Early Detection (MCED) at-home breath and urine tests: www.owlstonemedical.com/about/news/2...

Zyme Communications @zymecommunications.bsky.social · Oct 2

@bio-rad.bsky.social has announced a strategic agreement with Gencurix that will establish Bio-Rad as the exclusive distributor of Gencurix’ CE-IVD Droplex™ digital PCR oncology testing kits throughout Europe.

More here: rb.gy/67rc7e

Zyme Communications @zymecommunications.bsky.social · Sep 30

Tagomics published a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics’ ActivaceTM platform
➡️ bit.ly/4nmE2FU

Zyme Communications @zymecommunications.bsky.social · Sep 25

Miebach Consulting has expanded its facilities at Abingdon Science Park, doubling its footprint with a new bespoke space in The Science Quadrant.

Delivered by Kadans Science Partner, the new facilities offer flexible workspaces to support future growth: www.kadans.com/news/miebach...

Zyme Communications @zymecommunications.bsky.social · Sep 23

Today SynGenSys announced the launch of NK.SET™, the first commercially available NK (natural killer) cell-specific promoter library enabling precise and controllable gene expression.

Read the full press release here: www.syngensys.com/resources/nk

Zyme Communications @zymecommunications.bsky.social · Sep 23

Today Atelerix announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for research and diagnostics, improving access to its non-cryogenic cell preservation solutions.

Read more: shorturl.at/uFlyo

Zyme Communications @zymecommunications.bsky.social · Sep 22

Today @trimtechtx.bsky.social announced it has been named as one of Fierce Biotech’s ‘Fierce 15’ for 2025.

The company is creating novel, aggregate-selective, targeted protein degraders to combat neurodegenerative and inflammatory diseases such as Alzheimer’s.

Read more: shorturl.at/IRTJO

Zyme Communications @zymecommunications.bsky.social · Sep 18

Today Closed Loop Medicine announced the U.S. launch of WeDosify, the Company’s first commercially available product, which enables clinicians to personalize GLP-1 titration at scale.

Read more: www.closedloopmedicine.com/closed-loop-...